The aim of this study was to determine the maximum tolerated dose of a fixed dose of docetaxel when combined with continuous infusion ifosfamide, with and without G-CSF support, in the treatment of ...
The My Child Matters Programme: The Effect of the Implementation of a Childhood Cancer Care Network (ReNaCI) in the Treatment Abandonment of Acute Lymphoblastic Leukemia in Paraguay This is an ASCO ...
A dose-finding study was undertaken to determine the maximum-tolerated dose, and the recommended dose of docetaxel in combination with 12-h timed (22:00–10:00) flat infusion of 5-fluorouracil (5-FU) ...
The usefulness of PET/CT and diffusion-weighted MRI in pancreatic cancer. Background: In USA, adjuvant chemoradiotherapy is standard treatment for resectable gastric cancer. But compared to the ...
The demographics of this cohort are presented in Table 1. The mean age at diagnosis was 53 years in the HSR group and 58 in the non-HSR group (P = .02). All 58 patients, including 36 ovarian cancers ...
Anthony V. D'Amico, MD, PhD; Wanling Xie, MS; Elizabeth McMahon, RN; Marian Loffredo, RN, OCN; Shana Medeiros; David Joseph, MD; Jim Denham, MD; Parvesh Kumar, MD ...
Dec. 4, 2003 (San Antonio) — Docetaxel (Taxotere) produced better overall survival and longer time to progression than paclitaxel (Taxol) in a randomized head-to-head trial of the two taxanes widely ...
The US FDA has warned that intravenous administration docetaxal formulations contain alcohol and may cause intoxication among patients. A product label revision is being made. The U.S. Food and Drug ...
BRIDGEWATER, NJ – June 5, 2004 – Aventis announced today the results of a phase III trial using Taxotere® (docetaxel) Injection Concentrate when added to a standard therapy for nonresectable locally ...
WASHINGTON -- Sequencing docetaxel prior to second-generation androgen-blocking therapies may improve survival outcomes for men with metastatic castration-resistant prostate cancer (mCRPC), a ...
Treatment with Dato-DXd reduced the risk of disease progression or death by 25% vs docetaxel. The Food and Drug Administration (FDA) has accepted the Biologics License Application for datopotamab ...
Amid a shortage of standard-of-care chemotherapy drugs, Sagent Pharmaceuticals is pulling two lots of its docetaxel injection from U.S. shelves after receiving a report of potential particulate matter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback